Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Endometrial Cancer

Clinical Trial at: Compass Oncology - Tigard

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

12123 SW 69th Avenue
Tigard, Oregon 97223
155.78 mi. away
P: (971) 708.7600

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Compass Oncology - Portland

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, Oregon 97213
156.06 mi. away
P: (503) 239-7767

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Compass Oncology - Portland

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

265 North Broadway
Portland, Oregon 97227
158.30 mi. away
P: (503) 280-1223

More Details View Practice Page